PRAIS 2.0 – Página 211 – Plataforma Regional sobre Acceso e Innovación para las Tecnologías de la Salud

Voluntary Recall of Certain Over-the-Counter Products

Murilo Freitas - 04:00, 20 de julio de 2022514

Family Dollar is initiating a voluntary retail level product recall of certain products regulated by the U.S. Food and Drug Administration (FDA) that were stored and inadvertently shipped to certain stores on or around May 1, 2022 through June 10, 2022 due to product being stored outside of labeled

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/voluntary-recall-certain-over-counter-products

twitter-es

Keeping a safe distance from others and avoiding crowds reduces your risk of catching and spreading COVID-19 🦠. Protect yourself

admin - 14:41, 19 de julio de 2022576

Keeping a safe distance from others and avoiding crowds reduces your risk of catching and spreading COVID-19 🦠.

Protect yourself & others ❤️.

Learn more about how you can stay safe ➡️ paho.org/en/covid-19-co…

#GetVaxxed #COVID19 https://t.co/hVqb3Yz3qy

twitter-es

See how agencies of the Global Action Plan for Healthy Lives and Well-being for All #SDG3GAP are supporting Costa Rica

admin - 11:46, 19 de julio de 2022486

See how agencies of the Global Action Plan for Healthy Lives and Well-being for All #SDG3GAP are supporting Costa Rica towards more equitable, gender-responsive, and community-led #PHC for the #SDGs

@UNDP @UNFPA @UNICEF @WHO
youtu.be/fv44l3DvS9Q

rss-es

Smiths Medical Recalls Certain Medfusion 3500 and 4000 Syringe Infusion Pumps for Software Issues That May Impact Infusion Delivery

Murilo Freitas - 04:00, 19 de julio de 2022493

Software issues affecting certain Medfusion Syringe Infusion Pumps could impact infusion delivery to patients.

http://www.fda.gov/medical-devices/medical-device-recalls/smiths-medical-recalls-certain-medfusion-3500-and-4000-syringe-infusion-pumps-software-issues-may

rss-es

Sotrovimab para el tratamiento de pacientes con COVID-19

Murilo Freitas - 00:00, 19 de julio de 2022496

Sotrovimab para el tratamiento de pacientes con COVID-19
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1379533

rss-es

Nirmatrelvir-ritonavir (Paxlovid) para el tratamiento de pacientes con COVID-19: [2 de julio de 2022]

Murilo Freitas - 00:00, 19 de julio de 2022457

Nirmatrelvir-ritonavir (Paxlovid) para el tratamiento de pacientes con COVID-19: [2 de julio de 2022]
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1379549

rss-es

FDA Conducting Evaluation of Key Agency Activities to Strengthen Operations

Murilo Freitas - 19:58, 18 de julio de 2022522

FDA Conducting Evaluation of Key Agency Activities to Strengthen Operations
http://www.fda.gov/news-events/press-announcements/fda-conducting-evaluation-key-agency-activities-strengthen-operations

rss-es

FDA Roundup: July 19, 2022

Murilo Freitas - 17:31, 18 de julio de 2022495

FDA Roundup: July 19, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-july-19-2022

twitter-es

.@WHO and UNICEF sound the alarm as new data 📊 shows global vaccination coverage continued to decline in 2021, with

admin - 15:59, 18 de julio de 2022562

.@WHO and UNICEF sound the alarm as new data 📊 shows global vaccination coverage continued to decline in 2021, with 25 million infants missing out on lifesaving vaccines 🩹.
paho.org/en/news/15-7-2…

twitter-es

RT @WHO: As childhood vaccination rates fall, the risk of outbreaks like measles & polio increases. #VaccinesWork to help keep

admin - 12:34, 18 de julio de 2022401

RT @WHO: As childhood vaccination rates fall, the risk of outbreaks like measles & polio increases. #VaccinesWork to help keep us safe from…